JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, C.
Right arrow Articles by Brand, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, C.
Right arrow Articles by Brand, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 35, 24625-24632, August 27, 1999


Differential Effects of Lipopolysaccharide and Tumor Necrosis Factor on Monocytic Ikappa B Kinase Signalsome Activation and Ikappa B Proteolysis*

Claudia FischerDagger , Sharon PageDagger , Marion Weber, Tamara Eisele, Dieter Neumeier, and Korbinian Brand§

From the Institute of Clinical Chemistry and Pathobiochemistry, Klinikumrechts der Isar, Technical University Munich, Ismaninger Strasse 22, 81675 Munich, Germany

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The inflammatory mediators lipopolysaccharide (LPS) and tumor necrosis factor (TNF) are potent activators of NF-kappa B. This study compared the effect of these stimuli on endogenous Ikappa B kinase (IKK) signalsome activation and Ikappa B phosphorylation/proteolysis in human monocytic cells and investigated the role of the signalsome proteins IKK-alpha , IKK-beta , NF-kappa B-inducing kinase (NIK), IKK-gamma (NF-kappa B essential modulator), and IKK complex-associated protein. Kinase assays showed that TNF elicited a rapid but short-lived induction of IKK activity with a 3-fold greater effect on IKK-alpha than on IKK-beta , peaking at 5 min. In contrast, LPS predominantly stimulated IKK-beta activity, which slowly increased, peaking at 30 min. A second peak was observed at a later time point following LPS stimulation, which consisted of both IKK-alpha and -beta activity. The endogenous levels of the signalsome components were unaffected by stimulation. Furthermore, our studies showed association of the IKK-alpha /beta heterodimer with NIK, Ikappa B-alpha and -epsilon in unstimulated cells. Exposure to LPS or TNF led to differential patterns of Ikappa B-alpha and Ikappa B-epsilon disappearance from and reassembly with the signalsome, whereas IKK-alpha , IKK-beta , and NIK remained complex-associated. NIK cannot phosphorylate Ikappa B-alpha directly, but it appears to be a functionally important subunit, because mutated NIK inhibited stimulus-induced kappa B-dependent transcription more effectively than mutated IKK-alpha or -beta . Overexpression of IKK complex-associated protein inhibited stimulus-mediated transcription, whereas NF-kappa B essential modulator enhanced it. The understanding of LPS- and TNF-induced signaling may allow the development of specific strategies to treat sepsis-associated disease.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacterial lipopolysaccharide (LPS),1 a glycolipid membrane component, accounts for many of the cellular responses to Gram-negative infections, including sepsis and the development of septic shock (1). Once patients exhibit the septic shock syndrome and associated organ failure, a high mortality rate of the affected individuals is observed (1). The interaction of LPS with cells of, for example, the monocytic lineage appears to be especially important because subsequent cellular activation results in the release of highly active proinflammatory molecules, such as tumor necrosis factor (TNF) and interleukin (IL)-1beta , which in turn mediate systemic effects (2, 3). One of the key regulators of LPS-induced, as well as TNF- and IL-1beta -induced, gene expression at the interface between signal transduction and transcription is the transcription factor NF-kappa B (4-6).

There is an ever-increasing body of evidence that suggests that NF-kappa B/Rel plays an important role in gene regulation during inflammatory and immune reactions in a variety of disease settings (7-11). NF-kappa B regulatory sequences have been found in promoters or enhancers of numerous genes, e.g. coding for the proinflammatory cytokines TNF and IL-1beta ; the chemokines IL-8 and monocyte chemotactic protein-1; several adhesion molecules, including intercellular adhesion molecule-1 and vascular cell adhesion molecule-1; and the procoagulatory protein tissue factor (5, 12-15). The prototypic NF-kappa B dimer consists of the subunits p65 (RelA) and p50, although other subunits, such as c-Rel, RelB, and p52 have been identified (5). These dimeric NF-kappa B complexes are present in the cytosol in an inactive state bound to inhibitory proteins, collectively termed Ikappa B (5, 14, 15). Several Ikappa B proteins have been identified, including Ikappa B-alpha (16, 17), Ikappa B-beta (18), and the more recently cloned Ikappa B-epsilon (19). A variety of agents such as microbial pathogens (for example, LPS), as well as inflammatory or lymphoproliferative cytokines, including TNF and IL-1beta , induce the activation of NF-kappa B (5, 6, 14). This is mediated by a network of kinases leading to the phosphorylation of Ikappa B, which is subsequently degraded in an ubiquitin-dependent step by the proteasome, a multicatalytic high molecular weight protease system (16, 20-22). The removal of the inhibitor Ikappa B allows the translocation of the thus activated NF-kappa B dimer into the nucleus.

The signaling mechanisms that lead to the phosphorylation of Ikappa B, and thereby NF-kappa B activation, are only partly understood and characterized for TNF, IL-1beta , and LPS (23-27). A high molecular weight Ikappa B kinase (IKK) complex, also named the signalsome, has recently been identified, and it is postulated to represent a bona fide Ikappa B kinase (28-32). Several kinase-active components of this complex have been cloned, namely IKK-alpha , IKK-beta , and NF-kappa B-inducing kinase (NIK) (28-33). Furthermore, two adaptor or scaffold proteins have been found, IKK-gamma /NF-kappa B essential modulator (NEMO)/IKK-associated protein 1 (34-36) and IKK complex-associated protein (IKAP) (37), which have been suggested to stabilize the high molecular weight complex and/or regulate the kinase activity. Additional kinases, such as mitogen-activated protein kinase/extracellular-regulated kinase kinase kinase-1 (38) or mitogen-activated ribosomal S6 protein kinase (pp90rsk) (39), may assemble with the signalsome following activation of cells by certain stimuli. For example, activation of NF-kappa B by TNF appears to involve several upstream signaling proteins, including TRAF2 and RIP, which in turn activate NIK, thereby initiating a signaling pathway that results in Ikappa B phosphorylation (23-25).

It should be mentioned that the functionality of these IKK signalsome components has been mostly established under relatively unphysiological overexpression conditions in easy to handle cell lines, such as HeLa, 293, or Chinese hamster ovary B (28-32). TNF and IL-1beta were almost exclusively used as activators of these systems (28-32), although LPS has recently been reported to activate IKK (27). The regulation of expression and activation of endogenous signalsome components in cell types and conditions relevant for inflammation has not been investigated in great detail. The present study was therefore designed to compare the effect of TNF and LPS on endogenous IKK signalsome activation and Ikappa B phosphorylation/proteolysis in monocytic cells. In addition, we investigated the involvement of IKK-alpha , IKK-beta and NIK, as well as the adaptor proteins IKK-gamma (NEMO) and IKAP, in these signaling cascades.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture Conditions and Reagents-- THP-1 human monocytic cells (Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany) were maintained in suspension in RPMI 1640 (Glutamax-1, low endotoxin, Seromed, Berlin, Germany) containing 7% fetal calf serum (Myoclone super plus, low endotoxin, BioWhittaker, Walkersville, MD), 100 units/ml penicillin and 100 µg/ml streptomycin (Life Technologies, Inc., Eggenstein, Germany) as described (40). For the experiments, the cells were plated at a density of 3 × 106 cells/well in six-well culture dishes. Peripheral blood mononuclear cells were isolated from blood samples of normal donors by the Ficoll-Hypaque method as described (41). Monocytes were isolated from mononuclear cells by adherence to achieve a purity of approximately 90% as determined by flow cytometry. The adherent monocytes were cultured overnight in the same medium as THP-1 cells with 10% fetal calf serum before the experiment was started. LPS (Escherichia coli 0111:B4) and TNF were purchased from Sigma. Endotoxin contamination was screened by the limulus amoebocyte lysate assay (BioWhittaker), and only reagents with an endotoxin content of <10 pg/ml were used in the experiments. A potential toxicity of the cell culture conditions applied was monitored by cell morphology and count, trypan blue dye exclusion, and the WST-1 cell toxicity test (Roche Molecular Biochemicals, Mannheim, Germany).

Polyacrylamide Gel Electrophoresis and Western Blot Analysis-- Cytosolic extracts were isolated as described earlier (42). Electrophoresis was performed with 12.5% polyacrylamide gels (0.1% SDS) as described previously (40). The proteins were transferred to a nitrocellulose membrane using the wet blotting technique. After transfer, the membranes were incubated with polyclonal antibodies against the carboxyl-terminal domains of the inhibitors Ikappa B-alpha , -beta (Santa Cruz Biotechnology, Heidelberg, Germany), and -epsilon (a kind gift from Prof. N. Rice, NCI-Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, MD), against the kinases IKK-alpha , -beta , or NIK (Santa Cruz Biotechnology), as well as the scaffold protein IKK-gamma (using an antibody raised against the mouse homologue of human IKK-gamma , namely NEMO, a gift from Prof. Alain Israël and co-workers, Institut Pasteur, Paris, France), or with a monoclonal antibody against alpha -actin (Sigma). In some experiments, an antibody recognizing only the form of Ikappa B-alpha phosphorylated at Ser-32 was used (Calbiochem, Bad Soden, Germany). This incubation was followed by the appropriate horseradish peroxidase-conjugated secondary antibody (Dianova, Hamburg, Germany). The protein was visualized on x-ray film using the Western blot chemiluminescent reagent plus (NEN Life Science Products). The protein size was confirmed by molecular weight standards (Amersham Pharmacia Biotech, Braunschweig, and Bio-Rad).

Immunoprecipitation-- Cytosolic extracts were subjected to immunoprecipitation (IP) (35, 43) in either TNT buffer (200 mM NaCl; 20 mM Tris-HCl, pH 7.5; 1% Triton X-100; 1 mM dithiothreitol; 0.5 µM 4-(2-aminoethyl)-benzenesulfonyl fluoride; and 0.75 µg/ml each leupeptin, antipain, aprotinin, pepstatin A, and chymostatin; Sigma) or TN buffer (as TNT but without Triton X-100). Unspecific binding was blocked by incubation with 1 µg of normal rabbit IgG (Santa Cruz Biotechnology) and 25 µl of 6% protein A-agarose (Roche Molecular Biochemicals) for 30 min at 4 °C followed by immunoprecipitation for 2 h at 4 °C with 1 µg of anti-kinase antibody (Santa Cruz Biotechnology) and 25 µl of 6% protein A-agarose. After washing three times with TNT/TN buffer as appropriate and three times with kinase buffer (20 mM HEPES, pH 8.0; 10 mM MgCl2; 100 µM Na3VO4; 20 mM beta -glycerophosphate; 50 mM NaCl; 2 mM dithiothreitol; 0.5 µM 4-(2-aminoethyl)-benzenesulfonyl fluoride; and 0.75 µg/ml each leupeptin, antipain, aprotinin, pepstatin A, and chymostatin), the precipitated proteins were either analyzed by Western blot or kinase assay.

Kinase Assay-- IP was carried out as described above and followed by the kinase assay (35, 43). The kinase reaction was performed in kinase buffer for 30 min at 30 °C in the presence of 5 µCi of [gamma -32P]ATP (NEN Life Science Products) and 500 ng of the substrate GST-Ikappa B-alpha (Santa Cruz Biotechnology). Proteins were analyzed on 12.5% polyacrylamide gels (0.1% SDS), dried, and visualized by autoradiography.

Transfection of THP-1 Cells-- The following reporter plasmids were utilized in transfection studies: 3xkappa B.luci, a firefly luciferase reporter plasmid containing three copies of a prototypic (5'-GGGACTTTCC-3') kappa B site (42); TNFkop.luci, comprising 1108 base pairs of the TNF promoter region (42); and pGL2-IL-8, containing 420 base pairs of the IL-8 promoter region (44). Overexpression plasmids used in our studies included IKK-alpha , IKK-beta , NIK (wild type and mutated forms), IKAP (all gifts from Tularik Inc., South San Francisco, CA), NEMO, Ikappa B-epsilon (wild type and mutated), Ikappa B-beta (gifts from Prof. Alain Israël and co-workers, Institut Pasteur), and antisense IKK-alpha (a gift from Prof. Michael Karin, University of California-San Diego, La Jolla, CA). RcCMV (Invitrogen, Groningen, Netherlands) containing no insert was used as a negative control in the overexpression experiments. These plasmids, either alone or in combination, were transiently co-transfected with a constitutively active Renilla luciferase control plasmid, pRLtk (Promega, Mannheim, Germany), into THP-1 cells using a DEAE-dextran-based protocol (13, 44). After transfection, cells were plated out at a density of 2 × 106 cells/3 ml of RPMI medium with 7% fetal calf serum in a six-well plate and incubated for 2 days. After this time, the cells were stimulated for 5 h with either TNF or LPS. Subsequent to stimulation, the cells were lysed, and the luciferase activity was determined using the dual luciferase reporter assay system (Promega). The results are expressed as firefly luciferase relative light units divided by the values in relative light units obtained for the Renilla luciferase.

Pulse-Chase-- Pulse-chase experiments were carried out as described (40). Briefly, THP-1 cells were washed in complete medium (RPMI 1640 medium) without Met/Cys (BioWhittaker) and resuspended in this medium at a density of 3 × 106 cells/ml. After incubation in a 12.5-cm2 culture flask at 37 °C and 5% CO2 for 30 min, 100 µCi of [35S]Met/Cys (NEN Life Science Products) was added, followed by a labeling time of 3 h. The cells were then washed in the above-mentioned medium plus 500 µM Met/Cys (Boehringer Ingelheim, Ingelheim, Germany), resuspended in this medium, and plated out at a density of 3 × 106cells/well in a 12-well plate. The plate was returned to the incubator, and extracts were made at various times later. Cytosolic and nuclear extracts were prepared as described (42), except that the nuclei were incubated in Buffer B (0.02 M HEPES, pH 7.0, 0.1 M KCl, 0.1 M NaCl, 5 mM dithiothreitol, 5 mM phenylmethylsulfonyl fluoride, 20% glycerol, and 0.75 µg/ml each leupeptin, antipain, aprotinin, pepstatin A, chymostatin, Sigma) plus 0.5% Nonidet P-40 for 30 min on ice prior to disruption by drawing through a narrow pipette tip. Trichloroacetic acid-precipitated proteins were assayed for cpm. IP of equal volumes of protein was carried out using an anti-IKK-alpha or -beta antibody, and the resulting protein precipitate was separated by SDS-polyacrylamide gel electrophoresis. Autoradiographs of the vacuum-dried gels were analyzed densitometrically, the values were corrected for the cpm loaded, and the half-life was calculated for each protein.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Differential Activation of IKK-alpha and -beta -- Initial experiments were performed to assess potential selective effects of LPS and TNF on endogenous kinase-active signalsome subunits in human monocytic cells. Kinase assays were carried out to monitor the activity of IKK-alpha and -beta following incubation with these stimuli. Cytosolic extracts from THP-1 cells were subjected to IP with an anti-kinase antibody and the ability of the precipitated proteins to phosphorylate GST-Ikappa B-alpha in vitro was analyzed. It should be mentioned that 1% Triton X-100, present in the TNT buffer used for IP, disrupts the integrity of the signalsome complex (data not shown; see also Fig. 3), allowing us to distinguish between IKK-alpha and -beta activity.

TNF stimulation (1.6 ng/ml) elicited a rapid but rather short-lived effect, with a maximum response from both IKK-alpha and -beta at 5 min of incubation (Fig. 1A), although the IKK-alpha activity was greater than that of IKK-beta . TNF-induced IKK-alpha activity then decreased sharply after 20 min and had reached near base-line levels by 75 min. A similar pattern was observed for IKK-beta (Fig. 1A and data not shown).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Differential activation of endogenous IKK-alpha and -beta by TNF and LPS in monocytic cells. A, cytosolic extracts from THP-1 cells incubated with TNF (1.6 ng/ml) were subjected to IP using TNT buffer with either IKK-alpha or -beta antibodies as indicated. A kinase assay was performed using the substrate GST-Ikappa B-alpha , and the proteins were separated by SDS-polyacrylamide gel electrophoresis. 32P-Phosphorylated (circled P) GST-Ikappa B-alpha is shown by the arrow. B, THP-1 cells were incubated with LPS (1 µg/ml) for the times indicated, and IP followed by kinase assay for IKK-alpha and -beta activity was performed as in A. C, comparison between LPS- and TNF-induced IKK activity. Experiments were performed as described in A and B, and the peak activities (TNF, 5 min; LPS, 30 min) were analyzed. Representative films were scanned and quantified densitometrically. Induction above base line was calculated, and the results are depicted. D, kinase assays were performed as described in B, and the two peak activities of IKK after LPS stimulus (30 and 75 min) were analyzed as in C.

On the other hand, LPS stimulation (1 µg/ml) had a major effect on IKK-beta activity, which slowly increased and peaked at 30 min (Fig. 1B), whereas an almost negligible increase in the activity of IKK-alpha was observed at this time point. We also detected a second peak of IKK activity, comprising both IKK-alpha and -beta activation, following LPS stimulation at 75 min (Fig. 1B and see below).

The peak IKK activities induced by TNF (at 5 min) or LPS (at 30 and 75 min) were analyzed by densitometry and compared. In general, the activation of IKK by TNF was much more pronounced than that mediated by LPS at the time points of peak activation (Fig. 1C). The effect of TNF on IKK-alpha was 3-fold greater than that on IKK-beta at 5 min of incubation, whereas LPS almost exclusively activated IKK-beta after a 30-min stimulation period (Fig. 1, C and D). However, at 75 min of incubation, LPS appeared to induce both IKK-alpha and -beta activity, to approximately the same extent (Fig. 1D).

Stimulus-induced IKK-alpha and -beta Activity ex Vivo in Human Monocytes-- Kinase assays were also performed with cytosolic extracts from human adherent monocytes following either TNF (1.6 ng/ml) or LPS (100 ng/ml) stimulation. The experiments showed that TNF rapidly induced IKK activity (IKK-alpha  > IKK-beta ) with an early peak at 5 min (Fig. 2A). Similar to the effect seen in THP-1 cells, LPS exposure led to a slow increase in predominantly IKK-beta activity with a peak at 30 min (Fig. 2B).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Activation of IKK ex vivo in human monocytes. Adherent human monocytes were stimulated with TNF (1.6 ng/ml) (A) or LPS (100 ng/ml) (B) for the times indicated. IP of cytosolic extracts with either IKK-alpha or -beta antibodies in TNT buffer was carried out as shown, and kinase assays with GST-Ikappa B-alpha as substrate were performed as in Fig. 1. 32P-Phosphorylated GST-Ikappa B-alpha (circled P) is shown by the arrows.

The Role of NIK in Ikappa B Phosphorylation-- Next, we tested whether monocytic endogenous NIK, another kinase-active signalsome component, can itself directly phosphorylate Ikappa B-alpha substrate. For this purpose, IP with an antibody raised against NIK was performed under different conditions. As already mentioned, the presence or absence of Triton X-100 in the IP buffer is important with respect to the integrity of the precipitated complex. TN buffer (without detergent) or TNT buffer (1% Triton X-100) was used in the IP step following LPS or TNF stimulation of THP-1 cells. The subsequent kinase assay showed that in the absence of detergent, a strong kinase activity following LPS stimulation was detected (Fig. 3, TN). However, when detergent was present and the precipitated protein was almost exclusively NIK alone (data not shown), no phosphorylation of the substrate was observed (Fig. 3, TNT). A similar result was seen when TNF was used as the stimulus (Fig. 3). It should be noted that in some experiments, the peak activity following exposure to TNF was observed at an earlier time point than 5 min. The results suggest that in monocytic cells, NIK itself cannot phosphorylate the substrate Ikappa B-alpha . The activity seen in the absence of Triton X-100 must be due to kinases that have co-precipitated with NIK in the signalsome complex.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   NIK does not directly phosphorylate Ikappa B-alpha in monocytic cells. Cytosolic extracts from LPS- or TNF-stimulated THP-1 cells were immunoprecipitated with anti-NIK antibody in the presence (TNT) or absence (TN) of the detergent Triton X-100. Kinase assays were carried out as described in Fig. 1. Circled P, phosphorylated form.

Level of the Signalsome Components in Monocytic Cells-- Before further analysis of the signalsome complex (see below), we wanted to establish the presence and level of endogenous Ikappa B kinase-active components and associated subunits of the signalsome in monocytic cells. An additional aim was to examine whether the endogenous concentration of these molecules is changed following incubation with potent monocyte activators, such as LPS and TNF. For this purpose, THP-1 monocytic cells were incubated with LPS or TNF, and the level of IKK-alpha , -beta , and -gamma (NEMO), as well as of NIK, was determined by Western blot analysis.

In unstimulated monocytic cells, we detected a significant endogenous level of all the above-mentioned signaling proteins (IKK-alpha , IKK-beta , NIK, and IKK-gamma ), as shown in Fig. 4. Following treatment with LPS or TNF, the levels of IKK-alpha and IKK-beta (Fig. 4A and data not shown), as well as NIK and IKK-gamma (Fig. 4B and data not shown), were not significantly altered, suggesting a tight regulation of these components in monocytes. As a control, the concentration of alpha -actin was also monitored; its level was not influenced by any of the incubation conditions used (Fig. 4A).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 4.   Level of endogenous signalsome components in monocytic cells. THP-1 cells were treated with LPS, and cytosolic extracts were examined by Western blot for the presence of IKK-alpha and -beta (A) or NIK and IKK-gamma (B) proteins. alpha -Actin levels were assayed as a loading control; in A, a representative blot for the experiment is shown.

Northern blotting for the mRNA coding for IKK-alpha and -beta revealed only a weak signal in both stimulated and unstimulated cells (data not shown). Because this low level of mRNA contrasts with the relatively high constitutive expression of the proteins in this system, we decided to investigate the half-lives of these kinases by pulse-chase analysis. Using this technique the half-life of endogenous IKK-alpha and -beta was found to be 12.8 ± 0.1 h (n = 2) and 12.7 ± 0.1 h (n = 2), respectively, which indicates a relatively high stability of both signaling molecules in monocytic cells.

Analysis of the Signalsome Complex-- The association of the endogenous kinase-active signalsome components (IKK-alpha , IKK-beta , and NIK) and the inhibitor proteins Ikappa B-alpha and -epsilon was investigated in monocytic cells under various conditions. Initially, IP using a monoclonal antibody raised against IKK-alpha was performed on cytosolic extracts, followed by Western blot analysis of the co-precipitated proteins. In the absence of detergent in the IP buffer, we saw the complex components IKK-beta and NIK, as well as bound Ikappa B-alpha and -epsilon , co-precipitated by the anti-IKK-alpha antibody from unstimulated cell extracts (Fig. 5 and data not shown), whereas in the presence of Triton X-100, only the directly precipitated protein was observed (data not shown). This demonstrated the occurrence of IKK-alpha /beta heterodimers in monocytic cells and showed that these subunits are already associated with NIK as well as Ikappa B-alpha and -epsilon in unstimulated cells. The complex precipitated in the absence of detergent, as far as we were able to ascertain, did not alter in IKK-alpha , IKK-beta , or NIK composition throughout treatment with LPS or TNF (Fig. 5 and data not shown). A different pattern was observed for Ikappa B-alpha , which, following LPS stimulation, slowly disappeared from the complex over 60 min, being undetectable at this time, and then gradually reassociated (Fig. 5A). This agrees with the phosphorylation and proteolysis pattern that we observed in parallel studies (Fig. 5A). In contrast, TNF stimulation led to a clear phosphorylation of Ikappa B-alpha after 1 min of incubation (Fig. 5B). This phosphorylated form remained bound to the complex until 5 min, at which time it disappeared. The inhibitor protein then reassembled with the signalsome complex by 45 min, in its unphosphorylated form. The other inhibitory protein, Ikappa B-epsilon , was also initially associated with the signalsome complex and, after TNF stimulation, gradually disappeared. It was not found to reassociate, which is presumably due to the limited time frame studied here (see also Fig. 8).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 5.   Composition of the monocytic signalsome complex following activation. THP-1 cells were incubated with LPS (A) or TNF (B) for the times indicated. IP+WB, Cytosolic extracts were prepared, and IP in TN buffer with anti-IKK-alpha was carried out. The precipitated proteins were then analyzed by Western blot for the presence of the signalsome components IKK-alpha and -beta , as well as Ikappa B-alpha and -epsilon . The double arrowhead for Ikappa B-alpha in B indicates the phosphorylated (upper) and unphosphorylated (lower) form. WB, in parallel experiments, cytosolic extracts were examined by Western blot for the presence of Ikappa B-alpha . In some cases, an antibody that exclusively recognizes this protein in its stimulus-induced phosphorylated form (circled P) was applied.

Overexpression of Wild Type or Mutated Kinase-active Signalsome Components-- Next, we examined the effect of the kinase-active proteins IKK-alpha and -beta , as well as NIK, on LPS- and TNF-induced kappa B-dependent transcription. We transfected THP-1 cells with overexpression vectors for both wild type and mutated kinases together with luciferase reporter plasmids.

Initially, transfection efficiency was assessed by Western blotting of cytosolic extracts from kinase-transfected THP-1 cells, using an antibody raised against the Flag tag present on the overexpressed proteins. This confirmed that the protein was being overexpressed at equal levels in our system and that the control vector without a tagged overexpression protein showed no signal (data not shown).

The effect of both wild type and mutated IKK-alpha , -beta , and NIK was investigated using TNF and LPS as stimuli and 3xkappa B.luci as a reporter plasmid. The mutated, kinase-inactive proteins were all able to reduce LPS- or TNF-induced kappa B-dependent transcription below the level seen with the wild type proteins, with an effectiveness of IKK-alpha  < IKK-beta  < NIK (Fig. 6A). NIK wild type alone, in the absence of a stimulus, was also capable of causing an increase in kappa B-dependent transcription (4.7-fold over the base-line level of transcription observed in the presence of mutated, kinase-inactive NIK). Neither wild type IKK-alpha nor -beta was able to affect transcription in the absence of a stimulus. In addition, antisense IKK-alpha , when overexpressed in THP-1 cells, was able to inhibit LPS-induced kappa B-dependent, as well as TNF promoter-dependent, transcription (data not shown), in contrast to the sense (i.e. wild type IKK-alpha ). The control vector RcCMV, which contains no inserted DNA, had no effect on transcription.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Overexpression of wild type and mutated kinase-active signalsome components. THP-1 cells were transiently transfected with overexpression plasmids for either wild type or mutated kinase-active signalsome components, together with 3xkappa B.luci and a Renilla luciferase constitutively expressed control plasmid. A 5-h stimulation with either LPS or TNF was followed by luciferase measurement using the dual luciferase reporter assay kit. Results are expressed as firefly relative light units divided by Renilla relative light units. A, wild type (wt) or mutated (mut.) IKK-alpha , IKK-beta , or NIK was transfected into cells that were stimulated as shown. B, double transfection experiments with co-transfection of two kinase elements were performed, and the cells were stimulated as indicated. C, triple transfection experiments were carried out, with all three kinases transfected together into the cells, in the combinations indicated. RLA, relative luciferase activity; Con, control, unstimulated cells.

Double transfections, in which either wild type or mutated IKK-alpha and -beta were transfected together into THP-1 cells, showed an increase in the effectiveness of the mutated kinases in inhibition of the LPS- and TNF-induced kappa B-dependent transcription (Fig. 6B).

Triple transfections, with all three kinases transfected at the same time into cells, showed that an inhibition of the LPS stimulus of 60% was achieved when all kinases were mutated and inactive (Fig. 6C). Mutation of just one of the kinases led to a partial inhibition of the stimulus, with inactive IKK-alpha having the weakest effect and mutated NIK having an effect almost as strong as that seen when all three kinases were inactive.

Transfection of Nonkinase Members of the Signalsome Complex-- To obtain some insight into possible functional aspects of the scaffold proteins IKAP and IKK-gamma (NEMO), transfection experiments were carried out. Interestingly, overexpression of IKAP or NEMO in THP-1 cells resulted in two contrasting effects. IKAP overexpression led to a partial inhibition of both LPS- and TNF-induced kappa B-dependent transcription, seen with either 3xkappa B.luci or IL-8 and TNF promoter-dependent constructs (Fig. 7A and data not shown). Both LPS- and TNF-induced 3xkappa B.luci or IL-8 promoter-dependent transcription were inhibited by approximately 50%. IKAP alone influenced kappa B-dependent transcription to a certain degree, leading to an increase of 2.2-fold above base-line. NEMO, however, caused a slight rise (1.6-fold) in the level of kappa B-dependent transcription, over and above the effect seen with LPS and TNF alone (Fig. 7B). In the absence of external stimuli, NEMO-transfected cells also showed a small increase (1.8-fold) in transcriptional activity over the base-line levels.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Overexpression of kinase-inactive subunits of the signalsome. THP-1 cells were transfected with a luciferase reporter plasmid (either 3xkappa B.luci or the IL-8 promoter-dependent construct as indicated), together with the Renilla control plasmid and IKAP (A) or NEMO (B) overexpression vector. The cells were either stimulated for 5 h with LPS (L) or TNF (T) or left untreated (C) and assayed as in Fig. 6. CMV indicates the empty overexpression vector RcCMV, used as a control.

Ikappa B Proteolysis and Overexpression of Ikappa B-epsilon and -beta -- To investigate whether the differential activities of IKK after LPS or TNF stimulation affect the proteolysis and resynthesis of the recently cloned Ikappa B-epsilon , as well as Ikappa B-beta , we studied the kinetics of Ikappa B degradation and subsequent resynthesis following either LPS or TNF stimulation. Maximal degradation of Ikappa B-epsilon occurs relatively late following LPS exposure, after a 90-min stimulus (Fig. 8A). This inhibitory protein was rapidly resynthesized, reaching base-line expression levels by 120 min of incubation. A similar degradation pattern was found for Ikappa B-beta after LPS challenge, but in contrast to Ikappa B-epsilon , this was not followed by resynthesis of the Ikappa B-beta protein, at least within the time frame studied here (Fig. 8A). Ikappa B-epsilon was degraded much more rapidly by incubation with TNF, with an almost complete degradation achieved by 10 min (Fig. 8B), followed by a relatively long lag phase and thereafter resynthesis of the protein by 75 min. Ikappa B-beta also quickly underwent proteolysis after TNF stimulation, with no significant resynthesis up to 120 min later (Fig. 8B).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 8.   Ikappa B proteolysis and overexpression of Ikappa B-epsilon and -beta . A, cytosolic extracts from THP-1 cells treated with LPS were examined by Western blot analysis for the presence of Ikappa B proteins as shown. B, the presence of these proteins was also investigated following TNF stimulation. C, wild type or mutated Ikappa B-epsilon overexpression plasmids were transfected into THP-1 cells, and the effect on kappa B-dependent, as well as IL-8 promoter-dependent, transcription following incubation with LPS (L), TNF (T) or in the absence of stimulus (C) was analyzed as described in Fig. 6. D, the effect of overexpression of Ikappa B-beta was assayed as described in C. CMV represents the empty RcCMV overexpression plasmid, used as a control.

We also examined the effect of overexpression of the inhibitory proteins Ikappa B-epsilon and -beta in THP-1 cells to investigate whether these proteins are involved in shutdown of NF-kappa B activity. A contrasting result was seen between the two proteins. Transfection of an Ikappa B-epsilon wild type vector led to a reduction in stimulus intensity of kappa B-dependent transcription following incubation with LPS or TNF (Fig. 8C). The mutated form of Ikappa B-epsilon , which cannot be phosphorylated, also caused inhibition of the above-mentioned stimulus-induced transcription and was in fact even more effective than the wild type molecule (Fig. 8C). Both 3xkappa B.luci and IL-8 promoter-dependent transcription was similarly affected. In contrast, Ikappa B-beta overexpression led to a reinforcement, rather than an inhibition, of the LPS- and TNF-induced stimulation for all the plasmids examined (Fig. 8D). The signal intensity was more markedly increased (3-fold) in 3xkappa B.luci-transfected than in IL-8 promoter construct-transfected cells. Ikappa B-beta overexpression alone, in the absence of external stimuli, led to a marginal rise in the level of transcription, more clearly visible in IL-8 promoter construct-transfected cells than in those transfected with 3xkappa B.luci.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Both LPS and TNF belong to the most potent activators of NF-kappa B in cells of the monocytic lineage (5, 6, 14). However, the signaling cascades leading to NF-kappa B activation induced by these stimuli appear to differ markedly (24, 26, 43). The present paper elucidates the effects of LPS, as well as TNF, on endogenous monocytic IKK signalsome activation and subsequent phosphorylation/proteolysis of the Ikappa B inhibitory proteins. Our study reveals that a completely different signalsome activation pattern results from incubation of cells with these two highly effective stimulating molecules.

Incubation of human monocytic cells with LPS predominantly activated IKK-beta in our kinase experiments using Ikappa B-alpha as a substrate with a slow increase leading to a peak of activation at 30 min. At this time point, only a negligible activation of IKK-alpha by LPS was observed. In addition, a second IKK activation peak was seen at a later time point (75 min), which consisted of both IKK-beta and IKK-alpha activity. This may be caused by continuous stimulation induced by the presence of LPS in the medium and/or autocrine mechanisms. A recent report describes the activation of IKK by LPS in THP-1 cells (but does not distinguish between IKK-alpha and -beta ) with a maximum at 60 min (27). In these experiments, the exclusive dominant-negative expression of IKK-beta , but not IKK-alpha , partially inhibited LPS-induced transcriptional activity (27). This is in contrast to our study, as well as recently published results (26), in which the expression of both dominant-negative IKK-beta and IKK-alpha exerted inhibitory effects. The differences between these studies (peak of activation and effect of dominant-negative IKK-alpha ) could be due to differences in THP-1 sublines/cell types (13). When these data are taken together, our study indicates that IKK-beta is the major target of LPS signaling but also suggests a modest activation of IKK-alpha , especially at a later time point.

In contrast, TNF preferentially activated IKK-alpha with a dramatic, very early peak of activation at 5 min. Furthermore, a significant effect of TNF on IKK-beta activity was observed that was approximately 3-fold lower than that on IKK-alpha but showed a similar time course of activation. No second peak at a later time point was observed in the presence of TNF. A TNF-induced early peak of IKK activity was also observed in HeLa cells, when the whole signalsome complex was isolated and used for kinase assays, as well as in IKK-alpha and IKK-beta overexpression studies (28, 29, 32). In the latter experiments, equal effects of TNF and IL-1 on IKK-alpha and IKK-beta were observed (28), which contrasts with our TNF studies and may potentially be due to the fact that the functionality of overexpressed proteins does not precisely mirror the endogenous situation.

Our studies suggest that endogenous NIK, another kinase-active signalsome component (30, 31), is not able to directly phosphorylate Ikappa B-alpha following LPS or TNF exposure of monocytic cells. Nevertheless, transfection studies indicate that NIK may be a functionally important subunit of the complex because dominant-negative expression of NIK appeared to be even slightly more effective than that of IKK-alpha or IKK-beta in inhibiting LPS-induced, as well as TNF-induced, kappa B-dependent transcriptional activity. This may result from the more upstream orientation of NIK imposing a tight negative regulation over IKK (37). Recent overexpression studies in 293 cells demonstrate the association of NIK with IKK-alpha and, to a lesser extent, with IKK-beta (31) and the specific phosphorylation of Ser-176 of IKK-alpha by the NIK molecule (45).

In unstimulated monocytic cells, the endogenous signalsome contained IKK-alpha /IKK-beta heterodimers that appeared to be associated with NIK, Ikappa B-alpha , Ikappa B-epsilon , and presumably additional proteins not examined in this study (see also Ref. 37). Recently, it has been concluded from transfection experiments that heterodimers represent the most active IKK kinase subconfiguration (31). Following stimulation with LPS/TNF, the IKK proteins, as well as NIK, remained in the complex, whereas Ikappa B-alpha disappeared and at a later time point reassociated, a finding completely consistent with the stimulus-specific patterns of Ikappa B proteolysis and resynthesis observed in parallel experiments. A similar stimulus-induced release from the signalsome multimolecule was found for Ikappa B-epsilon . Interestingly, a recent study suggested that overexpressed IKK-alpha associates with Ikappa B-alpha bound to p65-p50, and it was proposed that phosphorylation induces the release of the inhibitor protein (30). A reverse approach demonstrated that mutations of Ser-32 and Ser-36 of Ikappa B-alpha (preventing phosphorylation) increased the signalsome association of the Ikappa B protein (31). At the structural level, it has been suggested that the kinase and leucine zipper domains of IKK-beta may be required for interaction with Ikappa B-alpha (31). This association pattern could also imply fine-tuned direct interactions between the high molecular weight complex signalsome, responsible for phosphorylation (28-32), and the proteasome, representing the degrading machinery (21, 22).

Another as yet unanswered question concerns the role of the kinase-inactive adaptor/scaffold proteins IKAP (37) and IKK-gamma (NEMO and IKK associated protein 1) (34-36) in signalsome-mediated signal transduction. In our studies, overexpression of IKAP in monocytic cells partially reduced LPS-stimulated, as well as TNF-stimulated, transcriptional activity. In 293 cells, an increased level of IKAP has been shown to inhibit TNF- and IL-1-induced kappa B-dependent transcription, and it was suggested that it may inhibit cytokine signaling by titrating out each individual component of the IKK signalsome (37), e.g. a higher level of IKAP may compete with kinase-active molecules. In contrast, the presence of exogenous NEMO enhanced both LPS- and TNF-induced transcription in our experiments. Recently, it has been shown that IKK associated protein 1 preferentially interacts with IKK-beta (36), and it has been suggested that this protein provides a scaffold upon which IKK-beta -containing complexes could be localized to the upstream components of the NF-kappa B activation cascade (34-36). Alternatively, a higher level of IKK-gamma in the signalsome may lead to an increased recruitment of the Ikappa B substrate or proteasome particles, which could also be a reason for the observed enhancement.

One technical issue should be discussed, and that is the reliability of transfection/overexpression studies. In our experiments, dominant-negative expression of IKK-alpha , IKK-beta , or NIK in monocytic THP-1 cells led only to a partial inhibition of both LPS- and TNF-activated kappa B-dependent transcription, with triple transfection most effective, in contrast to earlier studies using HeLa or 293 cells demonstrating a much more profound effect (26, 28, 31, 45). In addition, using the transfection strategies, we were not able to confirm the LPS- or TNF-induced differential pattern of IKK-alpha and IKK-beta activation seen in our kinase assays, which we consider a more clean and direct approach. Furthermore, we were not successful in establishing a direct effect of wild type IKK-alpha and IKK-beta on kappa B-regulated transcriptional activity observed under the cell culture and overexpression conditions already mentioned (28, 31). One reason for these discrepancies may be a technical problem, which is the low transfection efficiency using monocytic cells. Another reason could be that overexpression of proteins may create unphysiological conditions (46). For example, exogenously added IKK may form nonphysiological dimers/complexes, which may display lower or dysregulated kinase activities (31, 47). Therefore, endogenous IKK-alpha /beta heterodimers could overcome at least partially the effect of the specifically overexpressed proteins in monocytic cells and bias our results such that we did not achieve a clear cut kinase activation pattern.

When these data are taken together, LPS appears to only modestly but preferentially stimulate IKK-beta activity over a longer time interval, whereas the effect of TNF on the IKK kinase-active molecules (IKK-alpha  > IKK-beta ) is marked and rapid but appears to be rather limited. Because the effect of LPS on IKK activity was much weaker than that of TNF, one could argue that the IKK pathway represents just one of several parallel signaling pathways induced by LPS leading to NF-kappa B activation. In fact, LPS is known to initiate signal transduction cascades resulting in a spray-like activation of a network of kinases, G-proteins, cyclic nucleotide metabolizing enzymes, lipid second messengers, and ion channels, some of which even may be not related to NF-kappa B (2). Furthermore, additional kinases may be involved in LPS-mediated Ikappa B phosphorylation (39, 48, 49). On the other hand, a modest but continuous activation of IKK by LPS may prove essentially as effective as the rapid but short-lived activation of IKK seen following TNF challenge of cells. In this context, it should be noted that LPS or TNF led to a different proteolysis pattern of Ikappa B-alpha , -beta , and -epsilon in our work, which incidentally completely agreed with the IKK activation pattern, but finally led under both activation conditions to a marked removal of the inhibitory proteins.

One important issue that has to be addressed in the future is the question of why LPS induces slow motion signaling, whereas TNF activates a rapid motion pathway, and what signaling molecules are involved. In any case, the differential IKK activation pattern following LPS or TNF stimulation may provide therapeutical avenues: for example, the specific inhibition of IKK-beta would block LPS effects responsible for numerous deleterious effects in the organism but only partially inhibit TNF to a level potentially still required and sufficient for proper immune responses. Therefore, a deeper molecular understanding of how LPS and TNF affect cellular pathways may allow new approaches to improve the fatal outcome of the sepsis-associated wasting disease.

    ACKNOWLEDGEMENTS

We thank Dr. Mike Rothe (Tularik Inc.) (IKK-alpha , -beta , and NIK), Prof. Patrick A. Baeuerle (Tularik Inc.) (IKAP), and Prof. Michael Karin (AS-IKK-alpha ) for the generous gifts of the overexpression plasmids, as well as Prof. Alain Israël and co-workers for the gifts of Ikappa B-beta and Ikappa B-epsilon overexpression plasmids and the NEMO antibody. The luciferase reporter plasmids 3xkappa B.luci and the TNF promoter-dependent construct were from Prof. H. W. Löms Ziegler-Heitbrock, and the IL-8 promoter construct was from Prof. Nigel Mackman, to whom we are very grateful. We also thank Prof. Nancy Rice for the kind gift of Ikappa B-epsilon antibody. We also thank Drs. Monika Haas and Michael Page for valuable contributions and interesting discussions, as well as Nadja Kern for excellent technical assistance.

    FOOTNOTES

* This work was supported by Grants SFB 469 and Br 1026/3-2 from the Deutsche Forschungsgemeinschaft and Grant H 50-98 from the Medical Faculty of the Technical University of Munich.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger The first two authors contributed equally to this work.

§ To whom correspondence should be addressed. Tel.: 49-89-4140-4084; Fax: 49-89-4140-4875.

    ABBREVIATIONS

The abbreviations used are: LPS, lipopolysaccharide; TNF, tumor necrosis factor; IL, interleukin; IKK, Ikappa B kinase; NIK, NF-kappa B-inducing kinase; NEMO, NF-kappa B essential modulator; IKAP, IKK complex-associated protein; IP, immunoprecipitation; GST, glutathione S-transferase; CMV, cytomegalovirus.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Parillo, J. E. (1993) N. Eng. J. Med. 328, 1471-1477[Free Full Text]
2. Sweet, M. J., and Hume, D. A. (1996) J. Leukocyte Biol. 60, 8-26[Abstract]
3. Ulevitch, R. J., and Tobias, P. S. (1995) Annu. Rev. Immunol. 13, 437-457[CrossRef][Medline] [Order article via Infotrieve]
4. Bazzoni, F., and Beutler, B. (1996) N. Eng. J. Med. 334, 1717-1725[Free Full Text]
5. Siebenlist, U., Franzoso, G., and Brown, K. (1994) Annu. Rev. Cell Biol. 10, 405-455[CrossRef]
6. Müller, J. M., Ziegler-Heitbrock, H. W. L., and Baeuerle, P. A. (1993) Immunobiol. 187, 233-256[Medline] [Order article via Infotrieve]
7. Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., and Neumeier, D. (1996) J. Clin. Invest. 97, 1715-1722[Medline] [Order article via Infotrieve]
8. Baeuerle, P. A., and Baichwal, V. R. (1996) Adv. Immunol. 65, 111-137
9. Barnes, P. J., and Karin, M. (1997) N. Eng. J. Med. 336, 1066-1071[Free Full Text]
10. Böhrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Männel, D., Böttinger, B. W., Stern, D. M., Waldherr, R., Saeger, H.-D., Ziegler, R., Bierhaus, A., Martin, E., and Nawroth, P. P. (1997) J. Clin. Invest. 100, 972-985[Medline] [Order article via Infotrieve]
11. Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., and Gross, V. (1998) Gastroenterology 115, 357-369[CrossRef][Medline] [Order article via Infotrieve]
12. Brand, K., Fowler, B. J., Edgington, T. S., and Mackman, N. (1991) Mol. Cell. Biol. 11, 4732-4738[Abstract/Free Full Text]
13. Mackman, N., Brand, K., and Edgington, T. S. (1991) J. Exp. Med. 174, 1517-1526[Abstract/Free Full Text]
14. Grilli, M., Chiu, J. J.-S., and Lenardo, M. J. (1993) Int. Rev. Cytol. 143, 1-62[Medline] [Order article via Infotrieve]
15. Baldwin, A. S. (1996) Annu. Rev. Immunol. 14, 649-681[CrossRef][Medline]